{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:37:33Z","timestamp":1788241053798,"version":"build-2803163510"},"reference-count":64,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2016.00211","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T14:27:38Z","timestamp":1468506458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience"],"prefix":"10.3389","volume":"7","author":[{"given":"Andrew R.","family":"Gallimore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick J.","family":"Strassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"Aan Het Rot","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1213\/ANE.0000000000001009","article-title":"Target-controlled infusion: a mature technology","volume":"122","author":"Absalom","year":"2016","journal-title":"Anesth. Analg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1109\/10.81576","article-title":"A simple analytical solution to the 3-compartment pharmacokinetic model suitable for computer-controlled infusion pumps","volume":"38","author":"Bailey","year":"1991","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"B4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/dta.422","article-title":"A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010","volume":"4","author":"Barker","year":"2012","journal-title":"Drug Test. Anal."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/0006-2952(80)90169-0","article-title":"Metabolism of the hallucinogen n,n-dimethyltryptamine in rat-brain homogenates","volume":"29","author":"Barker","year":"1980","journal-title":"Biochem. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/archneurpsyc.1956.02330290012002","article-title":"Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication","volume":"76","author":"Belleville","year":"1956","journal-title":"AMA. Arch. Neurol. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1192\/bjp.104.435.445","article-title":"Dimethyltryptamine experiments with psychotics","volume":"104","author":"Boszormenyi","year":"1958","journal-title":"J. Mental Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/0269881114531666","article-title":"Repeated lysergic acid diethylamide in an animal model of depression: normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling","volume":"28","author":"Buchborn","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0378-8741(98)00168-8","article-title":"Pharmacokinetics of Hoasca alkaloids in healthy humans","volume":"65","author":"Callaway","year":"1999","journal-title":"J. Ethnopharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.mpaic.2012.02.011","article-title":"Principles of intravenous drug infusion","volume":"13","author":"Coetzee","year":"2012","journal-title":"Anaesth. Intensive Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1097\/00000542-199506000-00003","article-title":"Pharmacokinetic model selection for target controlled infusions of propofol - assessment of 3 parameter sets","volume":"82","author":"Coetzee","year":"1995","journal-title":"Anesthesiology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","article-title":"Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter","volume":"116","author":"Cozzi","year":"2009","journal-title":"J. Neural Transm."},{"key":"B17","first-page":"840","article-title":"Indolethylamine N-methyltransferase expression in primate nervous tissue","volume":"41","author":"Cozzi","year":"2011","journal-title":"Soc. Neurosci. Abstract Viewer Itinerary Planner"},{"key":"B18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/02791072.2005.10399807","article-title":"The ritual use of ayahuasca","volume":"37","author":"Frenopoulo","year":"2005","journal-title":"J. Psychoactive Drugs"},{"key":"B19","first-page":"455","article-title":"Building alien worlds - the neuropsychological and evolutionary implications of the Astonishing Psychoactive Effects of N,N-Dimethyltryptamine (DMT)","volume":"27","author":"Gallimore","year":"2013","journal-title":"J. Sci. Explor."},{"issue":"346","key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2015.00346","article-title":"Restructuring consciousness the psychedelic state in light of integrated information theory","volume":"9","author":"Gallimore","year":"2015","journal-title":"Front. Hum. Neurosci."},{"key":"B21","first-page":"291","article-title":"DMT research from 1956 to the edge of time","volume-title":"Neurotransmissions \u2013 An Anthology of Essays on Psychedelics from Breaking Convention, 1st Edn.","author":"Gallimore","year":"2015"},{"key":"B22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/bcp.12286","article-title":"Pharmacokinetic-pharmacodynamic modelling in anaesthesia","volume":"79","author":"Gambus","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-2005-916185","article-title":"Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers","volume":"38","author":"Gouzoulis-Mayfrank","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"B25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000467984","article-title":"Lsd-assisted psychotherapy in patients with terminal cancer","volume":"8","author":"Grof","year":"1973","journal-title":"Int. Pharmacopsychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/0269881113513851","article-title":"Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision","volume":"28","author":"Hendricks","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/00000542-200503000-00024","article-title":"Variability of target-controlted infusion is less than the variability after bolus injection","volume":"102","author":"Hu","year":"2005","journal-title":"Anesthesiology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1093\/schbul\/sbu029","article-title":"From phenomenology to neurophysiological understanding of hallucinations in children and adolescents","volume":"40","author":"Jardri","year":"2014","journal-title":"Schizophr. Bull."},{"key":"B29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.concog.2010.09.002","article-title":"Dreaming and waking: similarities and differences revisited","volume":"20","author":"Kahan","year":"2011","journal-title":"Conscious. Cogn."},{"key":"B30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1365-2044.1990.tb14416.x","article-title":"A portable computerized infusion system for propofol","volume":"45","author":"Kenny","year":"1990","journal-title":"Anaesthesia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1177\/0269881112439253","article-title":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","volume":"26","author":"Krebs","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"B32","first-page":"26","article-title":"Discarnate entities and dimethyltryptamine (DMT): Psychopharmacology, phenomenology and ontology","volume":"75","author":"Luke","year":"2011","journal-title":"J. Soc. Psychical Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/02791072.1998.10399714","article-title":"Treatment of alcoholism using psychedelic drugs: a review of the program of research","volume":"30","author":"Mangini","year":"1998","journal-title":"J. Psychoactive Drugs"},{"key":"B34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","article-title":"Monoamine-oxidase inhibitors in south-american hallucinogenic plants - tryptamine and beta-carboline constituents of ayahuasca","volume":"10","author":"McKenna","year":"1984","journal-title":"J. Ethnopharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/BF03010006","article-title":"Intravenous-infusion anesthesia and delivery devices","volume":"41","author":"Miller","year":"1994","journal-title":"Can. J. Anaesth."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1176\/ajp.154.7.1037b","article-title":"Hallucinogen-induced relief of obsessions and compulsions","volume":"154","author":"Moreno","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1038\/psp.2012.4","article-title":"Basic concepts in population modeling, simulation, and model-based drug development","volume":"1","author":"Mould","year":"2012","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/dta.1685","article-title":"Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study","volume":"7","author":"Riba","year":"2015","journal-title":"Drug Test. Anal."},{"key":"B40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s002130000606","article-title":"Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers","volume":"154","author":"Riba","year":"2001","journal-title":"Psychopharmacology"},{"issue":"204","key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2014.00204","article-title":"The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers","volume":"8","author":"Roseman","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"B42","first-page":"285","article-title":"Dimethyltryptamine: a new psycho-active drug (unpublished English translation)","volume":"135","author":"Sai-Halasz","year":"1958","journal-title":"Psychiatr. Neurol."},{"key":"B43","first-page":"925","article-title":"Accumulation of n,n-dimethyltryptamine in rat-brain cortical slices","volume":"14","author":"Sangiah","year":"1979","journal-title":"Biol. Psychiatry"},{"key":"B44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5771\/0257-9774-2012-1-276","article-title":"Ayahuasca, ritual, and religion in Brazil","volume":"107","author":"Schmidt","year":"2012","journal-title":"Anthropos"},{"key":"B45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1053-8100(02)00072-7","article-title":"Continuity between waking activities and dream activities","volume":"12","author":"Schredl","year":"2003","journal-title":"Conscious. Cogn."},{"key":"B46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF01070999","article-title":"Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump","volume":"20","author":"Shafer","year":"1992","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"B47","first-page":"125","article-title":"Altered states and the study of consciousness - the case of ayahuasca","volume":"24","author":"Shanon","year":"2003","journal-title":"J. Mind Behav."},{"key":"B48","volume-title":"The Antipodes of the Mind - Charting the Phenomenology of the Ayahuasca Experience","author":"Shanon","year":"2005"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/0006-2952(87)90159-6","article-title":"Urinary-excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat","volume":"36","author":"Sitaram","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0269881116628430","article-title":"Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide","volume":"30","author":"Speth","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B51","volume-title":"DMT - The Spirit Molecule.","author":"Strassman","year":"2001"},{"key":"B52","first-page":"51","article-title":"The varieties of the DMT experience","volume-title":"Inner Paths to Outer Space, 1st Edn.","author":"Strassman","year":"2008"},{"key":"B53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0166-4328(96)00081-2","article-title":"Human psychopharmacology of N,N-dimethyltryptamine","volume":"73","author":"Strassman","year":"1995","journal-title":"Behav. Brain Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","article-title":"Dose-response study of N,N-dimethyltryptamine in humans.1. Neuroendocrine, autonomic, and cardiovascular effects","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/0006-3223(95)00200-6","article-title":"Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans","volume":"39","author":"Strassman","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","article-title":"Dose-response study of N,N-dimethyltryptamine in humans.2. Subjective effects and preliminary results of a new rating scale","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"B57","first-page":"201","article-title":"DMT at fifty","volume":"9","author":"Szara","year":"2007","journal-title":"Neuropsychopharmacol. Hungarica"},{"key":"B58","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1002\/hbm.22562","article-title":"Enhanced repertoire of brain dynamical states during the psychedelic experience","volume":"35","author":"Tagliazucchi","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"B59","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/0020-708X(85)90257-1","article-title":"C-11 labeling of indolealkylamine alkaloids and the comparative-study of their tissue distributions","volume":"36","author":"Takahashi","year":"1985","journal-title":"Int. J. Appl. Radiat. Isot."},{"key":"B60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1037\/a0039242","article-title":"Subjective qualities of dreams with and without awareness","volume":"25","author":"Thomas","year":"2015","journal-title":"Dreaming"},{"key":"B61","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0893-133X(96)00246-1","article-title":"Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis","volume":"16","author":"Vollenweider","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2165\/00003088-200847020-00005","article-title":"Use of target controlled infusion to derive age and gender covariates for propofol clearance","volume":"47","author":"White","year":"2008","journal-title":"Clin. Pharmacokinet."},{"key":"B63","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.concog.2014.09.002","article-title":"Accounting for the phenomenology and varieties of auditory verbal hallucination within a predictive processing framework","volume":"30","author":"Wilkinson","year":"2014","journal-title":"Conscious. Cogn."},{"key":"B64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/BF00276707","article-title":"Invivo kinetics and displacement study of a carbon-11-labeled hallucinogen, n,n- c-11 dimethyltryptamine","volume":"12","author":"Yanai","year":"1986","journal-title":"Eur. J. Nucl. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T23:39:45Z","timestamp":1600904385000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphar.2016.00211\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,14]]},"references-count":64,"URL":"https:\/\/doi.org\/10.3389\/fphar.2016.00211","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,14]]}}}